Callan JMB Inc. (CJMB)
NASDAQ: CJMB · Real-Time Price · USD
0.7690
-0.0044 (-0.57%)
At close: Jun 2, 2026, 4:00 PM EDT
0.7500
-0.0190 (-2.47%)
Pre-market: Jun 3, 2026, 8:03 AM EDT
Callan JMB Revenue
Callan JMB had revenue of $1.11M in the quarter ending March 31, 2026, a decrease of -23.68%. This brings the company's revenue in the last twelve months to $5.38M, down -13.54% year-over-year. In the year 2025, Callan JMB had annual revenue of $5.72M, down -12.80%.
Revenue (ttm)
$5.38M
Revenue Growth
-13.54%
P/S Ratio
0.80
Revenue / Employee
$268,997
Employees
20
Market Cap
4.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.72M | -840.23K | -12.80% |
| Dec 31, 2024 | 6.56M | -6.64M | -50.29% |
| Dec 31, 2023 | 13.20M | -9.56M | -42.01% |
| Dec 31, 2022 | 22.77M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCJMB News
- 7 days ago - Callan JMB files $250M mixed securities shelf - TheFly
- 13 days ago - Callan JMB expands $175,000 per month infrastructure engagement - TheFly
- 13 days ago - Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement - GlobeNewsWire
- 6 weeks ago - Callan JMB announces The Atlas Complex in Alabama - TheFly
- 6 weeks ago - Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC - GlobeNewsWire
- 2 months ago - Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer - GlobeNewsWire
- 2 months ago - Callan JMB to provide oversight for JKB-122 manufacturing scale-up - TheFly
- 2 months ago - Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement - GlobeNewsWire